)
Nelly Viseux
VP Cell Therapies Development, Manufacturing Supply & Quality,
Regeneron Pharmaceuticals
Sessions
-
19-Jan-2027Theatre 1Session 1: Which process and analytical tools have the requisite flexibility, scalability, and cost-effectiveness to enable rapid clinical translation while laying the groundwork for later development and commercialisation? Part 1
-
20-Jan-2027Theatre 1Plenary: Plotting a course to sustainable future success for the cell & gene therapy industry